There are now real hope vaccines will be available in early 2021. The focus is now moving to the challenges surrounding the vaccine supply chain.
COVID-19, virtual trials, and a rapidly evolving supply chain
#supplychainmanagement…https://t.co/4nQZxeXPnF https://t.co/PsQGPrnf68
Three pressing Life Sciences priorities for 2021: What does the future of clinical trials, supply chains, and AI hold?
2020 Life Sciences predictions are now 2021 priorities https://t.co/w25qdfNjPs via @opentext
As we slowly emerge from the recent Covid-19 pandemic, the Life Sciences supply chain is faced with a period of profound change and disruption. How can companies adapt to this evolving landscape https://t.co/Zjbtf1HwBB
Long before this Coronavirus outbreak, I’d been speaking with Life Sciences and pharmaceutical companies about the need to ew-assess traditional business models to achieve the level of speed and innovation required for success. https://t.co/7km5QZwMQr